24 Jun 2016 09:49
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
EVG.L Share News (EVG)
EVG Share
Price
EVG Share
News
EVG Share
Chat
EVG Share
Trades
EVG
Live RNS
EVG Share
Charts
EVG Broker
Ratings
EVG Directors
Deals
EVG Financial
Diary
EVG
Fundamentals
EVG Short
Positions
EVG
Media
EVG.L Information
- There is currently no data for EVG
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Panmure Gordon boosted by US recovery
Wed, 05th Jan 2011 08:16
Stockbroker and investment bank Panmure Gordon has seen a significant improvement in its operating performance in the second half of the year. "Both our UK and US businesses generated operating profits in this six months, in spite of continued challenging trading conditions," it adds.UK investment banking saw a decent number of client transactions including fundraisings, M&A advisory and restructurings, while the US picked up after a very difficult first half of the year. The US business generated operating profits in every one of the last five months of the half year and was profitable at the operating profit level for the half year as a whole. US investment banking revenue for the year as a whole was more than five times that recorded in the first half of the year.Both the UK and the US have a good pipeline of deals for 2011, Panmure added.All costs incurred in dealing with the unsolicited bid approach from rival Evolution, and in settling the previously disclosed SPQR litigation and the US employee litigation will be treated as exceptional items in the year end numbers, Panmure added.Evolution ended its interest in making a bid in October after its initial proposal was rejected by Panmure's board.
More News
19 Jan 2016 14:59
Berkeley Group non-exec picks up first shares
(ShareCast News) - First Derivatives non-executive director David Anderson offloaded 5,000 shares in the software and consulting firm at 1,541p each. The sale brought his interest in the company down to 120,000 shares, or 0.5% of the issued share capital. Elsewhere, Berkeley Group non-executive dir
Read more4 Jan 2016 11:52
Evgen appoints new Chief Medical Officer
(ShareCast News) - Evgen Pharma announced the appointment of a new Chief Medical Officer on Monday. The AIM-listed clinical stage drug development company, focused on the treatment of cancer and neurological conditions, said Dr Hamina Patel would be appointed to the post. Dr Patel was described by
Read more9 Sep 2011 16:55
London close: Stocks dive on euro worries
The volatility continued heading into the weekend and stocks were nursing hefty losses at the close of play. The resignation of European Central Bank official Juergen Stark brought the Eurozone crisis into focus. Stark, a German, like many of his compatriots is unhappy about the Bank's policy of b
Read more9 Sep 2011 12:33
Broker tips: Home Retail, Premier Farnell, Evolution
Singer Capital Markets has slashed its target price for FTSE 250 retailer Home Retail Group by 29%, after the group's first half results showed continued tough trading at Argos and a challenging second quarter for Homebase. "Whilst not as bad as feared the continued weakness of trade at Argos and o
Read more9 Sep 2011 12:11
Broker snap: Peel Hunt ups target for Evolution after Investec offer
Following Investec's recommended offer for Evolution, Peel Hunt has raised its target price on the investment banking and stockbroking firm from 86p to 100p to reflect the offer price. Investec, the FTSE 100 South African banking titan, announced on Friday morning that it has made a recommended off
Read more